期刊文献+

ALK^+间变性大细胞淋巴瘤的临床特征、病理学研究进展及治疗策略

下载PDF
导出
摘要 对间变性大细胞淋巴瘤(anaplastic large-cell lymphoma,ALCL)的认识最初是基于其形态学特征和恒表达CD30,由Stein等[1]在1985年首先报道.现已明确ALCL起源于T或null淋巴细胞免疫表型.最新的WHO分类中将ALCL归类于外周T细胞淋巴瘤.40%~60%的ALCL患者有一个显著的临床病理学特征,即染色体t(2;5)(p23;q35)易位[2].这一染色体易位诱导形成核磷酸蛋白-间变性淋巴瘤激酶(nucleophosmin–anaplastic lymphoma kinase,NPM-ALK)融合蛋白.NPM- ALK由于持续激活酪氨酸激酶ALK而有显著的致癌潜力.下面,主要介绍ALK+ALCL的临床特征和病理学研究进展.
出处 《武警医学》 CAS 2012年第1期71-73,共3页 Medical Journal of the Chinese People's Armed Police Force
  • 相关文献

参考文献19

  • 1Stein H, Mason D Y, Gerdes J, et al. The expression of the Hodgkin' s disease associated antigen Ki - 1 in reactive and neo- plastic lymphoid tissue : evidence that Reed - Steinberg cells and histiocytic malignancies are derived from activated lymphoid cells [J]. Blood, 1985,66(4) : 848 -858.
  • 2Amin H M, Lai R. Pathobiology of ALK + anaplastic large - cell lymphoma[J]. Blood, 2007, 110(7) : 2259 -2267.
  • 3Dearden C E, Johnson R, Pettengell R, et al. Guidelines for the management of mature T - cell and NK - cell neoplasms ( exclu- ding cutaneous T -cell lymphoma) [ J]. Br J Haematol, 2011, 153(4) :451 -85.
  • 4Morris S W, Kirstein M N, Valentine M B, et al. Fusion of a ki- nase gene, ALK, to a nucleolar protein gene, NPM, in non - Hodgkin' s lymphoma[J]. Science, 1994,263 (5151) : 1281 - 1284.
  • 5Shiota M, Fujimoto J, Semba T, et al. Hyperphosphorylation of a novel 80 kDa protein - tyrosine kinase similar to Ltk in a human Ki - 1 lymphoma cell line, AMS3 [ J]. Oncogene, 1994, 9 ( 6 ) : 1567 - 1574.
  • 6Swerdlow S I-I, Campo E, Harris N L, et al. Eds. WHO Classifi- cation of Turnouts of Haematopoietic and Lymphoid Tissues [ J ]. Lyon : IARC, 2008:312 - 316.
  • 7Laurent C, Do C, Gaseoyne R D, et al. Anaplastic lymphoma ki- nase - positive diffuse large B - cell lymphoma: a rare clinico- pathologic entity with poor prognosis [ J ]. J Clin Oneol, 2009, 27 (25) :4211 -4216.
  • 8Falini B, Bigerna B, Fizzotti M, et al. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with awide morphological spectrum [ J ]. Am J Patho[, 1998,153:875 - 886.
  • 9Pearson J D, Lee J K, Bacani J T, et al. NPM - ALK and the JunB transcription factor regulate the expression of cytotoxic mole- cules in ALK -positive, anaplastic large cell lymphoma[ J]. Int J Clin Exp Pathol, 2011, 4(2) :124 -33.
  • 10Turner S D, Merz H, Yeung D, et al. CD2 promoter regulated nucleophosmin - anaplastic lymphoma kinase in transgenic mice causes B lymphoid malignancy [ J ]. Anticancer Res, 2006,26 : 3275 - 3279.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部